142 related articles for article (PubMed ID: 37540889)
21. Impact of paediatric onset primary sclerosing cholangitis on clinical course and outcome of inflammatory bowel disease: a case-control population-based study in Finland.
Tenca A; Jaakkola T; Färkkilä M; Arola J; Kolho KL
Scand J Gastroenterol; 2019 Aug; 54(8):984-990. PubMed ID: 31402720
[No Abstract] [Full Text] [Related]
22. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.
O'Toole A; Alakkari A; Keegan D; Doherty G; Mulcahy H; O'Donoghue D
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):439-41. PubMed ID: 22094024
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.
Shearn CT; Orlicky DJ; Petersen DR
Exp Mol Pathol; 2018 Feb; 104(1):1-8. PubMed ID: 29180269
[TBL] [Abstract][Full Text] [Related]
24. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis.
Stumme F; Steffens N; Steglich B; Mathies F; Nawrocki M; Sabihi M; Soukou-Wargalla S; Göke E; Kempski J; Fründt T; Weidemann S; Schramm C; Gagliani N; Huber S; Bedke T
Front Immunol; 2024; 15():1307297. PubMed ID: 38510236
[TBL] [Abstract][Full Text] [Related]
25. DNA content abnormality frequently develops in the right/proximal colon in patients with primary sclerosing cholangitis and inflammatory bowel disease and is highly predictive of subsequent detection of dysplasia.
Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Histopathology; 2023 Jul; 83(1):116-125. PubMed ID: 37012656
[TBL] [Abstract][Full Text] [Related]
26. Protective function of sclerosing cholangitis on IBD.
Bedke T; Stumme F; Tomczak M; Steglich B; Jia R; Bohmann S; Wittek A; Kempski J; Göke E; Böttcher M; Reher D; Franke A; Lennartz M; Clauditz T; Sauter G; Fründt T; Weidemann S; Tiegs G; Schramm C; Gagliani N; Pelczar P; Huber S
Gut; 2024 Jun; ():. PubMed ID: 38839272
[TBL] [Abstract][Full Text] [Related]
27. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.
Sokol H; Cosnes J; Chazouilleres O; Beaugerie L; Tiret E; Poupon R; Seksik P
World J Gastroenterol; 2008 Jun; 14(22):3497-503. PubMed ID: 18567077
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
[TBL] [Abstract][Full Text] [Related]
30. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
[TBL] [Abstract][Full Text] [Related]
31. The features of mucosa-associated microbiota in primary sclerosing cholangitis.
Torres J; Bao X; Goel A; Colombel JF; Pekow J; Jabri B; Williams KM; Castillo A; Odin JA; Meckel K; Fasihuddin F; Peter I; Itzkowitz S; Hu J
Aliment Pharmacol Ther; 2016 Apr; 43(7):790-801. PubMed ID: 26857969
[TBL] [Abstract][Full Text] [Related]
32. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
[TBL] [Abstract][Full Text] [Related]
33. PSC associated inflammatory bowel disease: a distinct entity.
Beheshti-Maal A; Tamimi A; Iravani S; Memarnejadian A; Sorouri M; Aghdaei HA; Zali MR; Hossein Khannazer N; Vosough M
Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):129-139. PubMed ID: 35078376
[TBL] [Abstract][Full Text] [Related]
34. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment.
Ricciuto A; Hansen BE; Ngo B; Aloi M; Walters TD; Church PC; Mazurek A; Khan M; Carman N; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1509-1517.e7. PubMed ID: 31493578
[TBL] [Abstract][Full Text] [Related]
35. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
[TBL] [Abstract][Full Text] [Related]
36. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.
Kim YS; Hurley EH; Park Y; Ko S
Exp Mol Med; 2023 Jul; 55(7):1380-1387. PubMed ID: 37464092
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
[TBL] [Abstract][Full Text] [Related]
38. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
Sano H; Nakazawa T; Ando T; Hayashi K; Naitoh I; Okumura F; Miyabe K; Yoshida M; Takahashi S; Ohara H; Joh T
J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):154-61. PubMed ID: 20740366
[TBL] [Abstract][Full Text] [Related]
40. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
